Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Kenneth A. Stauderman | Chief Scientific Officer | 2025-07-01 | 1,000 | $1.85 | $1.85kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-06-26 | 4,500 | $1.44 | $6.48kBuy |
Stephen Bardin | Chief Financial Officer | 2025-06-26 | 2,000 | $1.50 | $3.00kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-06-11 | 5,000 | $1.85 | $9.25kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-06-06 | 5,000 | $1.78 | $8.88kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2025-06-05 | 5,100 | $1.70 | $8.67kBuy |
Stephen Bardin | Chief Financial Officer | 2025-05-30 | 1,000 | $1.69 | $1.69kBuy |
Fred A. Middleton | Director | 2024-12-06 | 4,800 | $2.65 | $12.72kBuy |
Robert N. Wilson | Director | 2024-11-01 | 53,333 | $3.75 | $200.00kBuy |
A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | 2024-11-01 | 20,000 | $3.75 | $75.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James E. Flynn | 37.80% | 5,281,713 | $8.50M | Insider |
Orbimed Advisors LLC | 29.80% | 4,163,347 | $6.70M | Insider |
Fred A. Middleton | 22.58% | 3,155,250 | $5.08M | Insider |
Sanderling Venture Partners VI Co Investment Fund LP | 17.23% | 2,407,172 | $3.88M | Insider |
Sanderling Venture Partners VI LP | 16.60% | 2,319,428 | $3.73M | Insider |
Clarus Lifesciences III LP | 13.82% | 1,930,395 | $3.11M | Insider |
Christy L. Shaffer | 11.50% | 1,606,669 | $2.59M | Insider |
Deerfield Management Company LP Series C | 9.30% | 1,300,000 | $2.09M | Institution |
Hansoo Michael Keyoung | 8.11% | 1,133,596 | $1.83M | Insider |
Eric W. Roberts | 7.14% | 997,410 | $1.61M | Insider |